- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03563209
Assesment of Post-stroke Elbow Flexor Spasticity in Different Forearm Positions
Assesment of Post-stroke Elbow Flexor Spasticity in Response to Passive Stretch in Different Forearm Positions
Determination of which muscle is more spastic before injection of the botulinum toxin, and the application of the targeted treatment to that muscle results in more improvement in spasticity. It is known that the muscles that flex elbow in healthy individuals change according to forearm position. While the biceps brachii flexes the forearm in supination, the brachioradialis flexes the forearm in the neutral position. The brachialis muscle acts as a primary flexor muscle when the forearm is in pronation.
In this study, hypothesis is that the severity of spasticity differs depending on the forearm position.
Study Overview
Status
Conditions
Detailed Description
There are three main muscles that contribute to elbow flexor spasticity; musculus biceps brachii, musculus brachialis and musculus brachioradialis. Muscle selection in elbow flexor spasticity for botulinum toxin application has impact on treatment outcome. The superficiality of the biceps brachii muscle makes it an easy target for botulinum toxin injection. In dynamic electromyography studies, it has been reported that brachioradialis muscle is the most common contributor one to elbow flexion spasticity, followed by biceps brachii muscle. In the diagnostic selective nerve blocks, the brachialis muscle has been reported to be foreground.
Determination of which muscle is more spastic before injection of the botulinum toxin, and the application of the targeted treatment to that muscle results in more improvement in spasticity. Can the target muscle selection clinically be performed instead of methods such as electromyography where equipment is required and the evaluation period is relatively long? Can semi-quantitative methods used to assess the severity of spasticity provide reliable information regarding the muscle or muscles that contribute to elbow flexor spasticity? It is known that the muscles that flex elbow in healthy individuals change according to forearm position. While the biceps brachii flexes the forearm in supination, the brachioradialis flexes the forearm in the neutral position. The brachialis muscle acts as a primary flexor muscle when the forearm is in pronation.
The aim of this study is to investigate whether the severity of spasticity differs depending on the forearm position.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
In The USA Or Canada, Please Select...
-
İzmir, In The USA Or Canada, Please Select..., Turkey, 35360
- İlker Şengül
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Elbow flexor spasticity
- Grade 1 to 3 spasticity measured with Modified Ashworth Scale
- To agree to participate in the study
Exclusion Criteria:
- <18 years old
- Pregnancy
- Botulinum toxin injection within the last three months
- Presence of elbow contracture
- History of operation to spastic upper extremity
- Spasticity due to other causes other than stroke
- Do not agree to participate in the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Component of Spasticity (Spasticity Angle)
Time Frame: 1 day (Only one measurement was performed in time (cross-sectional))
|
According to the Modified Tardieu Scale, the difference between the angle of slow passive motion and the angle of muscle reaction represents the dynamic component of spasticity (spasticity angle) in degree.
A big difference suggests spasticity while the low difference suggests muscular contracture.
In this study, dynamic component of spasticity (spasticity angle) at forearm pronation, neutral position and supination was evaluated separately.
|
1 day (Only one measurement was performed in time (cross-sectional))
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: ilker şengül, Izmir Katip Celebi University
Publications and helpful links
General Publications
- Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206.
- Keenan MA. Management of the spastic upper extremity in the neurologically impaired adult. Clin Orthop Relat Res. 1988 Aug;(233):116-25.
- Genet F, Schnitzler A, Droz-Bartholet F, Salga M, Tatu L, Debaud C, Denormandie P, Parratte B. Successive motor nerve blocks to identify the muscles causing a spasticity pattern: example of the arm flexion pattern. J Anat. 2017 Jan;230(1):106-116. doi: 10.1111/joa.12538. Epub 2016 Sep 6.
- Keenan MA, Haider TT, Stone LR. Dynamic electromyography to assess elbow spasticity. J Hand Surg Am. 1990 Jul;15(4):607-14. doi: 10.1016/s0363-5023(09)90023-5.
- BASMAJIAN JV, LATIF A. Integrated actions and functions of the chief flexors of the elbow: a detailed electromyographic analysis. J Bone Joint Surg Am. 1957 Oct;39-A(5):1106-18. No abstract available.
- Gracies JM, Bayle N, Vinti M, Alkandari S, Vu P, Loche CM, Colas C. Five-step clinical assessment in spastic paresis. Eur J Phys Rehabil Med. 2010 Sep;46(3):411-21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21.02.2018-84
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-stroke Elbow Spasticity
-
Yonsei UniversityUnknownPost-Stroke Elbow SpasticityKorea, Republic of
-
Merz Therapeutics GmbHCompletedPost-stroke SpasticityAustria
-
IpsenCompleted
-
GlaxoSmithKlineCompletedSpasticity, Post-Stroke
-
IpsenCompletedPost-stroke Arm SpasticityGermany, Switzerland, Netherlands, Austria, France
-
Mackay Memorial HospitalCompletedPost-Stroke Upper Limb SpasticityTaiwan
-
National Yang Ming UniversityCompletedStroke | Chronic Stroke | Spasticity Post StrokeTaiwan
-
GlaxoSmithKlineCompletedSpasticity, Post-StrokeJapan
-
IpsenCompletedPost Stroke Arm SpasticityPoland
-
GlaxoSmithKlineCompleted